In efforts to develop new
treatments for brain cancer, scientists from Johns Hopkins Drug Discovery and the Kimmel Cancer Center's Bloomberg ~ Kimmel Institute for Cancer
Immunotherapy report they have altered the structure of an
experimental drug that seems to enhance its ability to slip through the mostly impermeable blood - brain barrier.